http://www.emedicine.com/emerg/topic574.htm
|

|

|
|
|
Sponsors
do not influence content.
|
|

|
AUTHOR
INFORMATION
|
Section 1 of
11   
|
Authored
by Daniel J Dire, MD, FACEP, COL, MC, USAR, USAWC Senior
Service Fellow, Center for Strategic Analysis, University of Texas at Austin
Daniel J Dire, MD, FACEP, COL, MC, USAR, is
a member of the following medical societies: American
Academy of Clinical Toxicology, American
Academy of Emergency Medicine, American
College of Emergency Physicians, American
Medical Association, Association of
Military Surgeons of the US, and Society for
Academic Emergency Medicine
Edited by Theodore Gaeta,
Residency Director, Clinical Associate Professor of Emergency Medicine in
Medicine, Department of Emergency Medicine, New York Methodist Hospital; Francisco
Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; John
Halamka, MD, Chief Information Officer, CareGroup Healthcare System,
Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel
Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical
School; and Charles V Pollack, Jr, MD, MA, University of
Pennsylvania College of Medicine, Associate Professor of Emergency Medicine,
Chairman, Department of Emergency Medicine, Pennsylvania Hospital
eMedicine Journal, May 18 2001, Volume 2, Number 5
|

|
INTRODUCTION
|
Section 2 of
11
 
|
Background:
Tetanus is an illness
characterized by an acute onset of hypertonia, painful muscular contractions
(usually of the muscles of the jaw and neck), and generalized muscle spasms
without other apparent medical causes.
Despite widespread immunization of infants
and children in the US since the 1940s, tetanus still occurs in the US. In the
1990s, tetanus is a severe disease primarily of older adults who are
unvaccinated or inadequately vaccinated.
Pathophysiology: Clostridium tetani, an obligate anaerobic, gram-positive bacillus, causes tetanus. This
bacterium is nonencapsulated and forms spores, which are resistant to heat,
desiccation, and disinfectants. The spores are ubiquitous and are found in
soil, house dust, animal intestines, and human feces.
Spores that gain entry can persist in normal
tissue for months to years. Under anaerobic conditions, these spores geminate
and elaborate tetanospasmin and tetanolysin. Tetanolysin is not felt to be of
any significance in the clinical course of tetanus. Tetanospasmin that is
released by the maturing bacilli is distributed via the lymphatic and vascular
circulations to the end plates of all nerves. Tetanospasmin then enters the
nervous system peripherally at the myoneural junction and is transported
centripetally into neurons of the central nervous system (CNS).
These neurons become incapable of
neurotransmitter release. The neurons, which release gamma-aminobutyric acid
(GABA) and glycine, the major inhibitory neurotransmitters, are particularly
sensitive to tetanospasmin leading to failure of inhibition of motor reflex
responses to sensory stimulation resulting in generalized contractions of the
agonist and antagonist musculature characteristic of a tetanic spasm. The
shortest peripheral nerves are the first to deliver the toxin to the CNS, which
leads to the early symptoms of facial distortion and back and neck stiffness.
Once the toxin becomes fixed to neurons, it
cannot be neutralized with antitoxin. Recovery of nerve function from tetanus
toxins requires sprouting of new nerve terminals and formation of new synapses.
Frequency:
- In the US: Reported incidence of tetanus has declined
substantially since the mid 1940s due to the widespread use of tetanus
immunizations. Picture 1 shows the reported number of tetanus cases and
average annual incidence rates, by state, in the US from 1995-1997.
Picture 2 shows the number of fatal cases of tetanus in the US reported to
the CDC from 1982-1991. Picture 3 shows the total number of cases of
tetanus reported to the CDC from 1947-1995. Some suggest that only 40% of
tetanus cases are reported to the CDC. From 1991-1994, 201 cases were
reported in the US. States with highest incidents reported from 1991-1994
were Texas and California. 124 cases were reported to the CDC from
1995-1997. 60% were ages 20-59 and 35% were 60 or older. All 50 states
require that children be vaccinated prior to admission to public schools.
More than 96% of children have received 3 or more diphtheria and tetanus
toxoids plus pertussis (DPT) vaccinations by the time they begin school.
Annual incidence has dropped to < 50
case per year in the US. The incidence in IV drug users increased from
3.6% of all cases from 1991-1994 to 11% of cases 1995-1997.
- Internationally: Worldwide, tetanus is predominantly a disease of
underdeveloped countries in warm, damp climates and affects all age
groups, with special preference for newborns and young persons. In 1992,
an estimated 578,000 infant deaths occurred due to neonatal tetanus. In
the beginning of the 1990s, an estimated 360,000 cases and 140,000 deaths
occurred each year from nonneonatal tetanus. Tetanus is one of the target
diseases of the World Health Organization Expanded Program on
Immunization. Overall annual incidence is 0.5-1 million cases.
Developed nations
have incidences of tetanus similar to that observed in the US. For instance,
only 126 cases were reported in England and Wales between 1984 and 1992.
Mortality/Morbidity: Overall, mortality is approximately 45%. The
mortality rate in the US is 6% for those who had previous received 1-2 doses of
tetanus toxoid to 15% for those unvaccinated.
- From 1995-1997, overall case fatality rate in the US was 11% which
is a drop from 25% during the period 1991-1994. All deaths were among
those older than 29 years.
- Mortality rate is highest for those older than 60 years (18%).
- Mortality rate is 30% for those who require mechanical ventilation,
but only 4% for those who do not.
Race: In the US, African Americans from the rural south
have a greater risk of tetanus.
Sex: A difference in the levels of tetanus immunity exists
between genders.
- Men are better protected than women, perhaps due to additional
vaccinations given during military service or professional activities.
- In the US from 1995-1997, 60% of the cases were in males.
- In developing countries, an increased immunity among women is
present where tetanus toxoid is administered to women of childbearing age
to prevent neonatal tetanus.
Age: Incidence of tetanus increases with advancing age. Of
the patients with tetanus in the US, 54% are older than 59 years and only 5%
are younger than 20 years.
History:
- In the US from 1995-1997, 81% of cases were generalized tetanus;
13% were localized; 6% were cephalic; and one cases of neonatal tetanus
were reported. From 1995-1997, 54% of the reported cases in the US had an
unknown tetanus vaccination history, 22% had no known previous tetanus
vaccination, 9% had 1 previous dose, 3 % had 2 previous doses, 3% had 3
previous doses, and 9% had 4 or more previous doses.
- The last reported case of neonatal tetanus in the US was in 1998
and this was only the second case since 1989.
- Most reported cases of tetanus worldwide are the neonatal type.
- Median incubation period is 7 days, and for
most cases (73%), incubation ranges from 4-14 days.
- This period is shorter than 4 days in 15% of
cases and longer than 14 days in 12% of cases.
- Those patients with clinical manifestations
occurring within 1 week of an injury have more severe clinical courses.
- Patients with generalized tetanus present with trismus (lockjaw) in
75% of cases.
- Other presenting complaints include stiffness,
neck rigidity, dysphagia, restlessness, and reflex spasms.
- Subsequently, muscle rigidity becomes the major
manifestation.
- Spread from the jaw and facial muscles occurs
over the next 24-48 hours to the extensor muscles of the limbs.
- Dysphagia occurs in moderately severe tetanus,
due to pharyngeal muscle spasms, and usually onset is insidious over
several days.
- Reflex spasms develop in the majority of
patients and can be triggered by minimal external stimuli such at noise,
light, or touch.
- The spasms last seconds to minutes, become more
intense, increase in frequency with disease progression, and can cause
apnea, fractures, dislocations, and rhabdomyolysis.
- Laryngeal spasms can occur at any time and can
result in asphyxia.
- Sustained contraction of facial musculature
produces a sneering grin expression known as risus sardonicus.
Physical:
- The site of antecedent acute injury is the lower extremity in 52%,
upper extremity in 34%, and head or trunk in 5% of patients.
- Autonomic dysfunction in patients with severe tetanus manifests as
extremes in blood pressure, dysrhythmias, and cardiac arrest.
- Neonatal tetanus presents with an inability to suck 3-10 days after
birth.
- Tetanic seizures may occur and portend a poor prognosis.
- Frequency and severity of seizures are related
to severity of the disease.
- They resemble epileptic seizures with the
presence of a sudden burst of tonic contractions
- However, the patient does not lose
consciousness and usually experiences severe pain.
- They frequently occur in the muscle groups
causing opisthotonos, flexion and abduction of the arms, clenching of the
fists on the thorax, and extension of the lower extremities.
- Localized tetanus is characterized by painful spasms of the group
of muscles in close proximity to the site of injury. This disorder may
persist for several weeks, but usually is self-limiting.
- Cephalic tetanus usually is secondary to chronic otitis media or
head trauma.
- It is characterized by variable cranial nerve
(CN) palsies; CN VII most frequently is involved.
- Ophthalmoplegic tetanus is a variant that
develops after penetrating eye injuries and results in CN III palsies and
ptosis.
- Untreated cases of cephalic tetanus progress to
generalized tetanus.
- Patients with tetanus may present with abdominal tenderness and
guarding, mimicking an acute abdomen.
- Patients have been taken to the operating room for exploratory
laparotomies before the correct diagnosis was apparent.
Causes:
- Tetanospasmin has a disinhibitory effect on the autonomic nervous
system (ANS).
- ANS dysfunction becomes progressively evident
as the level of toxin in the CNS increases.
- ANS disturbances, such as sweating, fluctuating
blood pressure, episodic tachydysrhythmia, and increased release of
catecholamines are observed.
- Drugs with beta-blocker effects have been used
to control the cardiovascular manifestations of ANS instability, but they
also have been associated with increased risk of sudden death.
- Only 12% of patients with tetanus in the US have received a primary
series of tetanus toxoid.
- In 77% of the cases in the US, tetanus occurred
after an acute injury, including 49% of puncture wounds, 22% of
lacerations, 12% of abrasions, and 2.6% of animal bites.
- Of those who obtained medical treatment for
their injury in the US from 1995-1997, 88% were administered Tetanus
Immune Globulin as a part of their treatment. 48% required the uses of
assisted ventilation and 18% of these died.
- Stepping on a nail accounted for 39% of the
puncture wounds.
- Tetanus can occur in burn victims, patients
receiving intramuscular injections, and with frostbite, dental infections
(eg, periodontal abscesses), penetrating eye injuries, and umbilical
stump infections.
- Other reported risk factors include diabetes,
chronic wounds (eg, skin ulcers, abscesses, gangrene), parenteral drug
abuse, and recent surgery (4% of cases in US).
- Median time interval between surgery and onset
of tetanus is 7 days.
- Tetanus has been reported after tooth
extractions, root canal therapy, and intraoral soft tissue trauma.
- Worldwide risk factors for neonatal tetanus
- Unvaccinated mothers, home delivery, and
unhygienic cutting of the umbilical cord
- History of neonatal tetanus in a previous child
- Potentially infectious substances applied to
the umbilical stump (eg, animal dung, clarified butter)
- Immunity from tetanus decreases with advancing age.
- Serological testing for immunity has revealed a
low level among the elderly in the US.
- Approximately 50% of adults older than 50 years
are nonimmune from having never been vaccinated or not receiving
appropriate booster doses.
- Prevalence of immunity to tetanus in the US is
greater than 80% for those aged 6-39 years, but only 28% for persons
older than 70 years.
|

|
DIFFERENTIALS
|
Section 4 of
11
 
|
Conversion
Disorder
Dislocations, Mandible
Encephalitis
Hypocalcemia
Meningitis
Peritonsillar Abscess
Rabies
Spider Envenomations,
Widow
Stroke, Hemorrhagic
Subarachnoid Hemorrhage
Toxicity,
Medication-Induced Dystonic Reactions
Other Problems to be Considered:
Intraoral disease
Odontogenic infections
Globus hystericus
Hepatic encephalopathy
Hysteria
Strychnine poisoning
Acute abdomen
Intracranial hemorrhage
|

|
WORKUP
|
Section 5 of
11 |